Swedish probiotic brand, BioGaia has bought a majority stake in Nutraceutics Corporation through a share acquisition valued at €8.6m (SEK8.9m) a new share issue of €4.4m (SEK45.4m) and plan to complete a full takeover within seven years.
The European Food Safety Authority (EFSA) rejects BioGaia’s health claim that asserts the consumption of its lozenges containing a probiotic blend can contribute to the maintenance of normal gum function.
Probiotics specialist BioGaia has extended a 2006 licensing
agreement with Swiss biopharma group Ferring Pharmaceuticals that
will see its probiotic drops and tablets distributed in a number of
predominantly Middle Eastern countries...
Swedish probiotics company BioGaia, which has made significant
developments in its health and nutrition unit this year, reported
net sales for 2002 reached SK43.1 million (€4.7m), with sales in
the fourth quarter up by 142 per cent...